Диссертация (1139667), страница 30
Текст из файла (страница 30)
The N Z Med J 125(1364): 68–76.139. Favilla CG, Ingala E, Jara J, et al. Predictors of finding occult atrial fibrillationafter cryptogenic stroke. Stroke. 2015;46(5):1210–1215.220140. Firbank M., Burton E.J., Barbur R. et al. Medial temporal atrophy rather thanwhite matter hyperintensities predicts cognitive decline in stroke survivors. NeurobiolAging 2007;28(11):1664–9.141. Fischer U, Baumgartner A, Arnold M, Nedeltchev K, Gralla J, De Marchis GM,et al. What is a minor stroke? Stroke.
2010; 41: 661–666.142. Fiske A, Wetherell J, Gatz M. Depression in older adults. Annu Rev ClinPsychol. 2009; 5:363–389.143. Flemming KD, Allison TG, Covalt JL, Herzig DE, Brown RD (2013) Utility ofa post-hospitalization stroke prevention program managed by nurses. Hosp Pract 41(3):70–9.144. Fukuuchi Y, Tohgi H, Okudera T, Ikeda Y, Miyanaga Y, Uchiyama S, HiranoM, Shinohara Y, Matsumoto M, Yamaguchi T. A randomized, double-blind studycomparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patientswith noncardioembolic cerebral infarction. Cerebrovasc Dis.
2008; 25:40-49.145. Furie K.L., Kasner S.E., Adams R.J. et al. Guidelines for the prevention ofstroke in patients with stroke or transient ischemic attack: a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association //Stroke.
2011; 42: 227-276.146. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al.Guidelines for the prevention of stroke in patients with stroke or transient ischemicattack: a guideline for healthcare professionals from the American HeartAssociation/American Stroke Association.
Stroke. 2011; 42: 227–276.147. Furie KL, Kasner SE, Adams RJ, et al; American Heart Association StrokeCouncil, Council on Cardiovascular Nursing, Council on Clinical Cardiology,Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for theprevention of stroke in patients with stroke or transient ischemic attack: a guideline forhealthcare professionals from the american heart association/american strokeassociation. Stroke. 2011;42(1):227–276.221148. Furlan AJ, Reisman M, Massaro J, et al; CLOSURE I Investigators. Closure ormedical therapy for cryptogenic stroke with patent foramen ovale.
N Engl J Med.2012;366(11):991–999.149. Gabaldon L, Fuentes B, Frank-Garcia A, Diez-Tejedor E. Poststroke depression:importance of its detection and treatment. Cerebrovasc Dis. 2007;24(1):181–188.150. Gaete J, Bogousslavsky J. Post-stroke depression. Expert Rev Neurother.2008;8(1):75–92.151. Gallagher-Thompson D, Steffen A, Thompson L, Vandenbulcke M.
Handbookof Behavioral and Cognitive Therapies with Older Adults. New York: Springer; 2008.152. Garcia-Cobos R., Frank-Garcia A., Gutierrez-Fernandez M., Diez-Tejedor E.Citicoline use in cognitive decline: vascular and degenerative // J. Neurol. Sci. 2010;299: 188-192.153. Gillham S, Endacott R (2010) Impact of enhanced secondary prevention onhealth behaviour in patients following minor stroke and transient ischaemic attack: arandomized controlled trial. Clin Rehabil 24: 822–830.154.
Giugliano RP, Ruff CT, Braunwald E, et al; ENGAGE AF-TIMI 48Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl JMed. 2013;369(22):2093–2104.155. Goldfinger JZ, Kronish IM, Fei K, Graciani A, Rosenfeld P, Lorig K, et al. Peereducation for secondary stroke prevention in inner-city minorities: Design and methodsof the prevent recurrence of all inner-city strokes through education randomizedcontrolled trial.
Contemp Clin Trials. -2012. - 33: 1065–1073.156. Gorelick P.B., Scuteri A., Black S.E. et al. Vascular contributions to cognitiveimpairment and dementia: a statement for healthcare professionals from the AmericanHeart Association/American Stroke Association // Stroke. 2011; 42(9): 2672-713.157. Gottesman R.F., Hillis A.E. Predictors and assessment of cognitive dysfunctionresulting from ischaemic stroke // Lancet Neurol. 2010; 9: 895-905.222158. Granger CB, Alexander JH, McMurray JJ, et al; ARISTOTLE Commit¬tees andInvestigators. Apixaban versus warfarin in patients with atrial fibrillation.
N Engl JMed. 2011;365(11):981–992.159. Greenberg S.M. Memory, executive function, and dementia. In Stroke recoveryand rehabilitation / Ed. by Stein J., Harvey R.L., Macko R.F., Winstein C.J., Zoro-witzR.D. — New York, USA: Demos Medical Publishing, 2009. — P. 213-220.160. Guo JJ, Xu E, Lin QY, Zeng GL, Xie HF. Effect of cilostazol on cerebralarteries in secondary prevention of ischemic stroke. Neurosci Bull. 2009; 25:383-390.161. Gusev E, Bogolepova A. Depressive disorders in stroke patients.
NeurosciBehav Physiol. 2009;39(7):639–643.162. Gutierrez J, Koch S, Dong C, et al. Racial and ethnic disparities in strokesubtypes: a multiethnic sample of patients with stroke. Neurol Sci. 2014;35(4):877–582.163. Hachinski V. World Stroke Day 2008 “Little Strokes, Big Trouble.” Stroke.2008; 39: 2407–2408.164. Hackett M, Anderson C, House A, Xia J. Interventions for treating depressionafter stroke. Stroke. 2009;40(7): 487– 488.165.
Hankey GJ, Johnston SC, Easton JD, Hacke W, Mas JL, Brennan D, Mak KH,Bhatt DL, Fox KA, Topol EJ. Effect of clopidogrel plus asa vs. Asa early after tia andischaemic stroke: A substudy of the CHARISMA trial. Int J Stroke. 2011; 6:3-9.166. Healey A, Kneebone I, Carroll M, Anderson S. A preliminary investigation ofthe reliability and validity of the Brief Assessment Schedule Depression Cards and theBeck Depression Inventory-Fast Screen to screen for depression in older strokesurvivors.
International Journal of Geriatric Psychiatry. 2008;23(5):531–536.167. Heiss WD, Zimmermann-Meinzingen S. PET imaging in the differentialdiagnosis of vascular dementia. J Neurol Sci. 2012 Nov 15;322(1-2):268-73.168. Hemmingsson T, v Essen J, Melin B, Allebeck P, Lundberg I. The associationbetween cognitive ability measured at ages 18–20 and coronary heart disease in middleage among men: a prospective study using the Swedish 1969 conscription cohort. SocSci Med.
2007; 65:1410–1419.223169. Hoffman TC, Erueti C, Glasziou PP (2013) Poor description of nonpharmacological interventions: analysis of consecutive sample randomised controlledtrials. BMJ 347: 3755.170. Hofmeijer J, van der Worp HB, Kappelle LJ, Amelink GJ, Algra A, vanZandvoort MJ. Cognitive outcome of survivors of space-occupying hemisphericinfarction. Neurol. 2013 Jan 10.171. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.
10-year follow-upof intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589.172. Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evalua¬tion ofthe Watchman Left Atrial Appendage Closure device in patients with atrial fibrillationversus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol.2014;64(1):1–12.173. Homma S, Thompson JL, Pullicino PM, et al; WARCEF Investigators. Warfarinand aspirin in patients with heart failure and sinus rhythm. N Engl J Med.2012;366(20):1859–1869.174. Homma S, Thompson JL, Sanford AR, et al; WARCEF Investigators.
Benefit ofwarfarin compared with aspirin in patients with heart fail¬ure in sinus rhythm: asubgroup analysis of WARCEF, a randomized controlled trial. Circ Heart Fail.2013;6(5):988–997.175. Hornnes N, Larsen K, Boysen G (2011) Blood Pressure 1 Year after Stroke: TheNeed to Optimize Secondary Prevention. J Stroke Cerebrovasc Dis 20(1): 16–23.Stroke Secondary Prevention: Systematic Review PLOS ONE | DOI:10.1371/journal.pone.0120902 March 20, 2015 23 / 25176.
Horowitz C, Fei K, Tuhrim S, Negron R, Kronish I (2013) A Peer-ledIntervention Improves Stroke Survivors’ Blood Pressure Control. [conference abstract]Stroke 44: AWP421.177. Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, Li Z, Zhang W, Ding M, Gao X,Fan D, Zeng J, Wong K, Lu C, Xiao J, Yao C. Cilostazol as an alternative to aspirin224after ischaemic stroke: A randomised, double-blind, pilot study. Lancet Neurol. 2008;7:494-499.178. Hurford R, Charidimou A, Fox Z, Cipolotti L, Werring DJ. Domain-specifictrends in cognitive impairment after acute ischaemic stroke.
J Neurol. 2013Jan;260(1):237-41.179. Ihle-Hansen H, Thommessen B, Fagerland MW, Oksengård AR, Wyller TB,Engedal K, Fure B. Multifactorial vascular risk factor intervention to prevent cognitiveimpairment after stroke and TIA: a 12-month randomized controlled trial. Int J Stroke.2012 Dec 4.180. Ikeda A, Yamagishi K, Tanigawa T, et al. Cigarette smoking and risk ofdisabling dementia in a Japanese rural community: a nested casecontrol.
Intern Med.2008; 168:1165–1173.181. International Carotid Stenting Study Investigators, Ederle J, Dobson J, et al.Carotid artery stenting compared with endarterectomy in patients with symptomaticcarotid stenosis (International Carotid Stenting Study): an interim analysis of arandomised controlled trial.
Lancet. 2010;375(9719):985–997.182. Jaillard A., Naegele B., Trabucco-Miguel S., Le Bas J.F., Hommel M. Hiddendysfunctioning in subacute stroke // Stroke. 2009; 40: 2473-2479.183. Jellinger K.A. Morphologic diagnosis of «vascular dementia»: a critical update// J. Neurol. Sci. 2008; 270: 1-12.184. Johnson G, Burvill P, Anderson C, Jamrozik K, Stewart-Wynne E, Chakera T.Screening instruments for depression and anxiety following stroke: experience in thePerth community stroke study.
Acta Psychiatr Scand. 2007;91(4):252–257.185. Johnston S, Mendis S, Mathers C (2009) Global variation in stroke burden andmortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 8(4):345–354.186. Johnston SC, Easton JD, Farrant M, et al. Platelet-oriented inhibition in newTIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke.2013;8(6):479–483.225187. Jorge R.E., Acion L., Moser D., Adams H.P. Jr., Robinson R.G. Escitalopramand enhancement of cognitive recovery following stroke // Arch. Gen. Psychiatry. 2010;67(2): 187-196.188. Joubert J, Reid C, Barton D, Ruth D, Jackson D, Sullivan JO, et al.
(2009)Integrated care improves risk factor modification after stroke: initial results of theIntegrated Care for the Reduction of Secondary Stroke Model. Jnl Neurol NeurosurgPsychiatry 80: 279–84.189. Kavirajan H., Schneider L.S. Efficacy and adverse effects of cholinesteraseinhibitors and memantine in vascular dementia: a meta–analysis of randomisedcontrolled trials. // Lancet Neurol. —2007.
— Vol.6, N9. — p.782 — 792.190. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, etal. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence(FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007; 6: 961–969.191. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vsincidental patent foramen ovale in cryptogenic stroke. Neurol¬ogy. 2013;81(7):619–625.192. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, EzekowitzMD, et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
